Farmako.Net

Farmako.net comprises a team of highly qualified executives in the fields of pharmaceutical science and IT. Our primary objectives revolve around making social contributions and safeguarding the ultimate good: health. Equally significant is gaining acceptance and trust from our users. To achieve this, Farmako.net diligently references its sources through appropriate hyperlinks in the information it presents. This allows healthcare professionals to easily and promptly verify the information from Farmako.net or delve into more comprehensive details if desired. The content of Farmako.net includes the following: • Drug search and presentation. • Search for drug indications using keywords. • Evaluation of drug interactions, encompassing interactions with food, herbs, and substances like drugs/psychotropics (heroin, cannabis, alcohol, etc.), as well as COVID-19 vaccines. • Detailed information on active substances. • 3D Anatomy. • Comparison charts (2023) for retail prices of similar custom products, along with retail price fluctuation charts over the past five years (2019 - 2023). • Exploration of PubMed using the International Classification of Diseases (ICD-10). • Categorization (risk) of drugs during pregnancy based on the Australian system. Farmako.net obtained permission from the Australian Government to republish the "Australian categorization system for prescribing medicines in pregnancy" upon its request. The main sources for Farmako.net include: • E.O.F (National Medicines Organization of Greece). • E.M.A (European Medicine Agency). • N.L.M (National Library of Medicine of the USA). • T.G.A (Therapeutic Goods Administration of Australia). • PubMed. • Drugs.com. • PubChem. After extensive and meticulous efforts, Farmako.net made its inaugural public appearance in November 2022. The initial reactions and comments surpassed all expectations, which fills us with great optimism and strengthens our resolve for the future. We remain hopeful for the best!